(Q33170261)

23 July 2017

title

Syncope and conduction disturbances following sublingual nifedipine for hypertension (English)

1 reference

23 July 2017

0 references

1 reference

Zangerle KF

1

1 reference

23 July 2017

Wolford R

series ordinal

2

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 October 1985

1 reference

Annals of Emergency Medicine

23 July 2017

published in

1 reference

23 July 2017

volume

14

1 reference

23 July 2017

issue

10

1 reference

23 July 2017

page(s)

1005-1006

1 reference

Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Role of nifedipine in treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Nifedipine in hypertensive emergencies.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Calcium channel blockers in emergency medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Nifedipine in the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Acute treatment of hypertensive crisis with nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

The effects of calcium channel blocking agents on cardiovascular function

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2885%2980250-X

7 January 2021

10.1016/S0196-0644(85)80250-X

Identifiers

DOI

1 reference

23 July 2017

1 reference